Abstract
Penicillins are a group of antibiotics of the beta-lactam group, widely used worldwide as first-choice drugs in the treatment of infections caused by sensitive bacteria. Their use is based on an empirical measure of their activity through antibiograms. In this work we have carried out a structure-activity relationship analysis to elucidate the molecular and physicochemical bases that determine the antibacterial activity and the orientation of the antibacterial spectrum of penicillins, employing a set of bacteria that cause common infections. It was found that the antibacterial activity increases as penicillin size increases for both, Gram-negative and Gram-positive bacteria. In the same way, liposolubility affects the activity; water soluble penicillins have greater activity on Gram-negative bacteria, while in some cases liposoluble penicillins present higher activity against Gram-positive bacteria. In addition, it is proposed that electronic properties of the substituent of the penicillin core determine its antibacterial spectrum. The electron donating substituents make the penicillin active against Gram-positive bacteria, while the electron withdrawing substituents gear the activity towards Gram-negative bacteria. In addition, the alpha-carbon (Cα) of the carboxamide side chain is also essential for the activity against Gram-negative bacteria; penicillins that lack it, have higher activity against Gram-positive bacteria.
Similar content being viewed by others
References
ACD/ChemSketch, Advanced Chemistry Development, Inc., Toronto, On, Canada, www.acdlabs.com. 2015
Adhikari R, Dutt-Pant N, Neupane S, Neupane M, Bhattarai R, Bhatta S, Chaudhary R, Lekhak B (2017) Detection of methicillin resistant Staphylococcus aureus and determination of minimum inhibitory concentration of vancomycin for Staphylococcus aureus isolated from pus/wound swab samples of the patients attending a tertiary care hospital in Kathmandu, Nepal. Can J Infect Dis Med Microbiol 2017:1–6
Alcaide F, Liñares J, Pallares R, Carratala J, Benitez MA, Gudiol F, Martin R (1995) In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 39(10):2243–2247
Alpuche ACM, Amaya-Burns A, Andrus JK, Aranda TE, Arathoon E, Arbo SA, Badaró R, Báez E, Basualdo W, Benguigui Y, Bologna R, Camba de Hernández I, Carter K, Castro J, Cimerman S, Clara L, Comegna M, Correa A, Cruz JR, Douce R, Graybaill R, Grazioso C, Gotuzzo E, Gusmao R, Guzmán BM, Heitmann I, Lerner SJ, Martin M, Mejía C, Paredes P, Pleités EB, Rocha MC, Rodríguez R, Salvatierra-González R, Schmuñis GA, Suárez CE, Zurita J (2004) Guía para el tratamiento de las enfermedades infecciosas. Organización Panamericana de la Salud: Oficina Regional de la Organización Mundial de la Salud. 1-294, Washington DC, USA
Álvarez S, Jones M, Berk SL (1985) In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 28(5):689–690
Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 49(6):1–16
Arlet G, Rouveau M, Fournier G, Lagrange PH, Philippon A (1993) Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins. Antimicrob Agents Chemother 37(9):2020–2023
Aubert G, Guichard D, Vedel G (1996) In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles. J Antimicrob Chemother 37(1):155–160
Ayers LW, Jones RN, Barry AL, Thornsberry C, Fuchs PC, Gavan TL, Gerlach EH, Sommers HM (1982) Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing. Antimicrob Agents Chemother 22(5):859–877
Baker P, Slots J, Genco R, Evans R (1983) Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria. Antimicrob Agents Chemother 24(3):420–424
Baker CN, Thornsberry C (1974) Antimicrobial susceptibility of Streptococcus mutans isolated from patients with endocarditis. Antimicrob Agents Chemother 5(3):268–271
Bornside GH (1968) Synergistic antibacterial activity of ampicillin-cloxacillin mixtures against Proteus morganii. J Appl Microbiol 16(10):1507–1511
Bou G, Oliver A, Martínez J (2000) OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 44(6):1556–1561
Brown A, Butterwoth D, Cole M, Hanscomb G, Hood J, Reading C, Rolinson G (1976) Naturally-occurring β-lactamase inhibitors with antibacterial activity. J Antibiot 29(6):668–669
Brown S, Young HK, Amyes SG (2005) Characterization of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 11(1):15–23
Brunton L, Hilal-Dandan R, Knollmann BC (2019) Goodman & Gilman: Las bases farmacológicas de la terapéutica. McGraw-Hill, Mexico, p 960
Cai JC, Zhou HW, Zhang R, Chen G-X (2008) Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase kpc-2 in intensive care units of a chinese hospital. Antimicrob Agents Chemother 52(6):2014–2018
Chartrand SA, Scribner RK, Weber AH, Welch DF, Marks MI (1983) In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother 23(5):658–663
Chin NX, Neu HC (1983) In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother 24(5):754–763
Crosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59
Da Silva G, Leitao R, Peixe L (1999) Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J Clin Microbiol 37(6):2109–2110
Deshpande LM, Jones RN (2003) Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci. Clin Microbiol Infect 9(11):1120–1124
Doern GV, Brueggemann A, Holley HP, Rauch AM (1996) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 40(5):1208–1213
Doern GV, Brueggemann AB, Huynh H, Wingert E, Rhomberg P (1999) Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997–98. Emerg Infect Dis 5(6):757–765
Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN (1998) Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 27(4):764–770
Dowson CG, Johnson AP, Cercenado E, George RC (1994) Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother 38(1):49–53
Eftekhar F, Raei F (2011) Correlation of minimum inhibitory concentration breakpoints and methicillin resistance gene carriage in clinical isolates of Staphylococcus epidermidis. Iranian J Med Sci 36(3):213–216
Eliopoulos GM, Thau vin C, Gerson B, Moellering RC (1985) In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother 27(3):357–362
Endimiani A, Choudhary Y, Bonomo RA (2009) In vitro activity of NXL104 in combination with β-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Antimicrob Agents Chemother 53(8):3599–3601
English AR, Retsema JA, Girard AE, Lynch JE, Barth WE (1978) CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother 14(3):414–419
Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st Century. Perspectives in Medicinal Chemistry 6:25–64
Farber B, Eliopoulos G, Ward J, Ruoff K, Syriopoulou V, Moellering R (1983) Multiply resistant viridans streptococci: Susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob Agents Chemother 24(5):702–705
Fass R (1983) In vitro activity of ciprofloxacin (Bay o 9867). Antimicrob Agents Chemother 24(4):568–574
Fass R (1991) In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against Staphylococci, Streptococci, and Enterococci. Antimicrob Agents Chemother 35(3):553–599
Fass RJ, Prior RB (1989) Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob Agents Chemother 33(8):1268–1274
Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ, Pascual A (2003) Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 51(3):565–574
Ford CW, Hamel JC, Wilson DM, Moerman JK, Stapert D, Yancey Jr RJ, Hutchinson DK, Barbachyn MR, Brickner SJ (1996) In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob Agents Chemother 40(6):1508–1513
Fu KP, Neu HC (1978a) Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother 13(6):930–938
Fu K, Neu H (1978b) Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother 13(3):358–367
Fuchs PC, Barry AL, Thornsberry C, Jones RN (1984) In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrob Agents Chemother 25(3):392–394
Ghose AK, Crippen GM (1987) Atomic physicochemical parameters for three-dimensional-structure-directed quatitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions. J Chem Informat Model 27(1):21–35
Gilbert DN, Chambers HF, Eliopoulos GM, Saag MS, Pavia AT, Black D, Freedman DO, Kim K, Schwartz BS (2016) Guía Sanford: Guía de Terapéutica Antimicrobiana 2016, 46a ED. A.W.W.E. Editorial Médica, USA
Gill VJ, Manning CB, Ingalls CM (1981) Correlation of penicillin minimum inhibitory concentrations and penicillin zone edge appearance with staphylococcal beta-lactamase production. J Clin Microbiol 14(4):437–440
Goldstein EJ, Citron DM (1986) Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother 29(1):158–160
Haller I (1984) Importance of extracellular and cell-bound beta-lactamase in mediating resistance of Staphylococcus aureus to mezlocillin. Antimicrob Agents Chemother 25(1):125–127
Hansch C, Fujita T (1964) J Am Chem Soc 86(8):1616–1626
Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL (2001) In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob Agents Chemother 45(3):825–836
Henry D, Skidmore AG, Ngui-Yen J, Smith A, Smith JA (1985) In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother 28(2):259–264
Héritier C, Poirel L, Fournier P-E, Claverie J-M, Raoult D, Nordmann P (2005) Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 49(10):4174–4179
Higgins PG, Wisplinghoff H, Stefanik D, Seifert H (2004) In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with β-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 48(5):1586–1592
Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN (2001) Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 15(32):S81–S93
Ikeda F (1990) Intrinsic penicillin resistance in penicillinase-producing Neisseria gonorrhoeae strains. Microbiol Immunol 34(1):1–9
Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC (1999) Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 u.s. surveillance study. Antimicrob Agents Chemother 43(8):1901–1908
Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley IA, Sader HS, Jones RN (2010) Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 54(6):2716–2719
Jones RN, Barry AL, Thornsberry C (1983) In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrob Agents Chemother 24(2):209–215
Jones RN, Fuchs PC, Sommers HM, Gavan TL, Al Barry, Gerlach EH (1980) Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin. Antimicrob Agents Chemother 17(4):750–756
Jones RN, Thornsberry C, Barry AL, Fuchs PC, Gavan TL, Gerlach EH (1977) Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin. J Antibiot 30(12):1107–1114
Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS (1990) Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 34(11):2075–2080
Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J (2015) Harrison: Principios de medicina interna. McGraw-Hill, China, p 930–1102
Kesado T, Hashizume T, Asahi Y (1980) Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrob Agents Chemother 17(6):912–917
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771
Knox R, Smith JT (1963) Stability of methicillin and cloxacillin to staphylococcal penicillinase. Br Med J 27(2):205–207
Lacy MK, Lu W, Xu X, Tessier PR, Nicolau DP, Quintiliani R, Nightingale CH (1999) Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother 43(3):672–677
Larsson S, Walder MH, Cronberg SN, Forsgren AB, Moestrup T (1985) Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden. Antimicrob Agents Chemother 28(1):12–14
Leo A, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem Rev 71(6):525–616
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26
Marques de Cantú MJ (1998) Probabilidad y estadística para ciencias químico-biológicas. McGraw-Hill, Mexico, p 425–456, 471–486
McCracken GH, Nelson JD, Thomas ML (1973) Discrepancy between carbenicillin and ampicillin activities against Enterococci and Listeria. Antimicrob Agents Chemother 3(3):343–349
McWhinney PH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC (1993) Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother 37(11):2493–2495
Miraglia GJ, Basch HI (1967) Activity of selected penicillins in vitro and in experimental bacterial infections in mice. Appl Microbiol 15(3):566–568
Miyazaki M, Nagata N, Miyazaki H, Matsu K, Takata T, Tanihara S, Kamimura H (2014) Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center. Biol Pharm Bull 37(4):679–682
Monif G, Clarck P, Shuster J, Baer H (1978) Susceptibility of the anaerobic bacteria, Group D Streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. Antimicrob Agents Chemother 14(5):643–649
Moody JA, Peterson LR, Gerding DN (1985) In vitro activity of ciprofloxacin combined with azlocillin. Antimicrob Agents Chemother 28(6):849–850
Nelson C, Mason E, Kaplan SL (1994) Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 13(7):585–589
Neu HC (1982) Penicillins-new insights into their mechanisms of activity and clinical use. Bull New York Acad Med 58(8):681–695
Neu HC, Aswapokee N, Fu KP, Aswapokee P (1979) Antibacterial activity of a new 1-oxa cephalosporin compared with that of other β-lactam compounds. Antimicrob Agents Chemother 16(2):141–149
Neu HC, Fu KP, Aswapokee N, Aswapokee P, Kung K (1979) Comparative activity and β-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob Agents Chemother 16(2):150–157
Neu HC, Labthavikul P (1982) Comparative in vitro activity of N-formimidoyl thienamycin against Gram-positive and Gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother 21(1):180–187
Neu HC, Meropol NJ, Fu KP (1981) Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother 19(3):414–423
Neu H, Winshell E (1972) Relation of 1-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins. Antimicrob Agents Chemotherapy 1(2):107–111
Nicolson K, Evans G, O´Toole P (1999) Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes. FEMS Microbiol Letters 179:233–239
Olsson B, Nord C-E, Wadström T (1976) Formation of Beta-Lactamase in Bacteroides fragilis: Cell-Bound and extracellular activity. Antimicrob Agents Chemother 9(5):727–735
Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N (1994) Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38(1):71–78
Overturf GD, Steinberg EA, Underman AE, Wilkins J, Leedom JM, Mathies Jr AW, Wehrle PF (1977) Comparative trial of carbenicillin and ampicillin therapy for purulent meningitis. Antimicrob Agents Chemother 11(3):420–426
Padrón JA, Pellón RF (2002) Molecular descriptor based on a molar refractivity partition using Randic-type graph-theoretical invariant. J Pharm Pharmaceut Sci 5(3):258–265
París MM, Ramilo O, McCracken GH (1995) Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 39(10):2171–2175
PC Spartan pro molecular modeling for the desktop (1999) Chemical & Engineering News Archive 77(17):2
Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P (1997) OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 41(10):2188–2195
Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P (2000) Biochemical sequence analyses of ges-1, a novel class an extended-spectrum β-lactamase, and the class 1 integron in52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44(3):622–632
Quinn J, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 33(9):1451–1456
Reading C, Cole M (1977) Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother 11(5):852–857
Reimer LG, Mirrett S, Reller LB (1980) Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates. Antimicrob Agents Chemother 17(3):412–416
Reimer LG, Stratton CW, Reller LB (1981) Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother 19(6):1050–1055
Rolston KV, LeFrock JL, Schell RF (1982) Activity of nine antimicrobial agents against Lancefield group C and group G streptococci. Antimicrob Agents Chemother 22(5):930–932
Sabath L, Garner C, Wilcox C, Finland M (1976) Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 Antibiotics. Antimicrob Agents Chemother 9(6):962–969
Sahm D, Jones M, Hickey M, Diakun D, Mani S, Thornsberry C (2000) Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998. J Antimicrob Chemother 45(4):457–466
Sanders CC (1981) Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against Gram-positive bacteria and Haemophilus influenzae. Antimicrob Agents Chemother 20(6):843–846
Sawai T, Yoshida T (1982) A simple method for testing the efficacy of a β-lactamase inhibitor against β-lactamase-producing Gram-negative bacteria. J Antibiot 35(8):1072–1077
Servicios de salud (2018) Datos estadísticos sobre principales problemas de salud pública. http://wwwssm.gob.mx/portal/index.php/2-uncategorised/11-salud-publica. Accessed 20 Jan 2019
Smith ECJ, Kaatz GW, Seo SM, Wareham N, Williamson EM, Gibbons S (2007) The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 51(12):4480–4483
Smith MB, March J (1992) March’s advanced organic chemistry: reactions, mechanisms, and structure. Chapters 1 and 9 John Wiley & Sons, Inc, USA, p 916–18. 363–374
Suh B, Bae K, Kim J, Jeong S, Young D, Lee K (2010) Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss. Antimicrob Agents Chemother 54(12):5057–5061
Sutherland R, Croydon EAP, Rolinson GN (1970) Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. Br Med J 4(5733):455–460
Sutherland R, Croydon EAP, Rolinson GN (1972) Amoxycillin: A new semi-synthetic penicillin. Br Med J 3(5817):13–16
Takata N, Suginaka H, Kotani S, Ogawa M, Kosaki G (1981) Beta-Lactam resistance in Serratia marcescens: comparison of action of benzylpenicillin, apalcillin, cefazolin, and ceftizoxime. Antimicrob Agents Chemother 19(3):397–401
Tanaka H, Sato M, Fujiwara S, Hirata M, Etoh H, Takeuchi H (2002) Antibacterial activity of isoflavonoids isolated from Erythrina variegata against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol 35:494–498
Taylor PC, Schoenknecht FD, Sherris JC, Linner EC (1983) Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother 23(1):142–150
Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT (1998) Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 41(6):621–627
Thijssen HHW, Mattie H (1976) Active metabolites of isoxazolylpenicillins in humans. Antimicrob Agents Chemother 10(3):441–446
Thomson KS, Moland ES (2004) CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. J Antimicrob Chemother 54(2):557–562
Toma E, Barriault D (1995) Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for Gram-positive cocci. J Clin Microbiol 33(7):1712–1715
Toshinobu H, Arakawa Y, Ohta M, Ichiyama S, Wacharotayankun R, Kato N (1993) Plasmid-mediated AmpC-type 1-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob Agents Chemother 37(5):984–90
Ubukata K, Nonoguchi R, Matsuhashi M, Konno M (1989) Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant s. aureus-specific penicillin-binding protein. J Bacteriol 171(5):2882–2885
Verbist L (1978) In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother 13(3):549–357
Vouillamoz J, Moreillon P, Giddey M, Entenza JM (2006) Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. J Antimicrob Chemother 58(6):1208–1214
Watanakunakorn C, Glotzbecker C (1979) Comparative in vitro activity of LY 127935 (6059-s), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin. J Antibiot 32(10):1019–1024
White GW, Malow JB, Zimelis VM, Pahlavanzadeh H, Panwalker AP, Jackson GG (1979) Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother 15(4):540–543
Williamson R, Hakenbeck R, Tomasz A (1980) In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother 18(4):629–637
World Health Organization (2018a) Wide differences in antibiotic use between countries, according to new data from WHO. https://www.who.int/medicines/areas/rational_use/oms-amr-amc-report-2016-2018-media-note/en/. Accessed 8 Jun 2019
World Health Organization (2018b) The top 10 causes of death. https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 30 Jan 2019
World Health Organization (2015) WHO publishes a set of best practices for the naming of new human infectious diseases. https://www.who.int/es/news-room/detail/08-05-2015-who-issues-best-practices-for-naming-new-human-infectious-diseases. Accessed Mar 2019
Yang YJ, Wu PJ, Livermore DM (1990) Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob Agents Chemother 34(5):755–758
Yotsuji A, Minami S, Inoue M, Mitsuhashi S (1983) Properties of novel β-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother 24(6):925–929
Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y (2017) Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation. Drug Des, Devel Ther 2017(11):1951–1956
Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ (1996) In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 40(4):839–845
Acknowledgements
This work was supported by Consejo Nacional de Ciencia y Tecnología (CONACyT; No. 257364) and SIP Project of Instituto Politécnico Nacional (No. 20181505).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
About this article
Cite this article
Morán-Díaz, J.R., Jiménez-Vázquez, H.A., Gómez-Pliego, R. et al. Correlation study of antibacterial activity and spectrum of Penicillins through a structure-activity relationship analysis. Med Chem Res 28, 1529–1546 (2019). https://doi.org/10.1007/s00044-019-02391-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02391-9